Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.

•Highly pathogenic avian influenza viruses pose an occupational risk to laboratorians.•The majority of survey respondents were interested in the Q-Pan H5N1 vaccine.•Interest in vaccination varied by role in the laboratory and time spent with HPAI viruses.•Q-Pan H5N1 vaccine could be used in tandem with current biosafety practices for HPAI laboratorians.